Beam Therapeutics is a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.
Recent Press Releases
September 8, 2021
August 10, 2021
Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results
August 3, 2021